🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the efficacy and safety of trastuzumab deruxtecan ...
Status
Active Not Recruiting
Location
Instituto Medico Especializado Alexander Fleming
Start Date
2021-05-21
Trial ID
NCT04704934
Treatments Being Tested
The purpose of this study is to evaluate the effects of ramucirumab in comb...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2012-12
Trial ID
NCT01703091
Treatments Being Tested
Previous studies provide a strong theoretical rationale for the conduct of ...
Status
Completed
Location
Institute for Clinical Cancer Research Krankenhaus Nordwest
Start Date
2016-06
Trial ID
NCT02661971
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as irinotecan hydrochloride, wo...
Status
Completed
Location
UAB Comprehensive Cancer Center
Start Date
2011-01-18
Trial ID
NCT01079780
Treatments Being Tested
This study is an open-label, international, multi-center, Phase 1 study in ...
Status
Terminated
Location
Mayo Clinic
Start Date
2023-08-10
Trial ID
NCT05980416
Treatments Being Tested
Primary Objectives: Part 1: to confirm the recommended tusamitamab ravtans...
Status
Terminated
Location
Investigational Site Number : 0560002
Start Date
2021-11-16
Trial ID
NCT05071053
Treatments Being Tested
The purpose of this study is to determine if doctors can use the results of...
Status
Completed
Location
University of Chicago
Start Date
2015-01-20
Trial ID
NCT02213289
Treatments Being Tested
The aim of this study is to evaluate the efficacy and safety of combination...
Status
Withdrawn
Location
Chonbuk National University Hospital
Start Date
2019-09-30
Trial ID
NCT03766607
Treatments Being Tested
The investigators hypothesize that this combination regimen of irinotecan p...
Status
Completed
Location
University of Miami - Sylvester Comprehensive Cancer Center
Start Date
2017-11-01
Trial ID
NCT03141034
Treatments Being Tested
Primary Objectives * In phase 1b cohort, to determine MTD (maximum tolerat...
Status
Recruiting
Location
Taipei Veterans General Hospital
Start Date
2024-04-01
Trial ID
NCT05927857
Treatments Being Tested